![]() |
市場調查報告書
商品編碼
1636651
到 2030 年探針再處理市場預測:按產品類型、探針類型、技術、應用、最終用戶和地區進行的全球分析Probe Reprocessing Market Forecasts to 2030 - Global Analysis By Product (Reprocessing Systems, Detergents & Disinfectants, Accessories and Other Products), Process Type, Probe Type, Technology, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球探針後處理市場價值為 8.448 億美元,預計在預測期內將以 12.5% 的複合年成長率成長,到 2030 年將達到 17.126 億美元。
探頭再處理是對診斷影像(例如超音波)中使用的醫用探頭和換能器進行清洗、消毒和滅菌的過程,以防止交叉污染和院內感染。該過程包括多個步驟,包括手動清洗、高水平消毒和滅菌,具體取決於風險等級。自動化系統通常用於提高效率並確保最佳的感染控制。其目的是確保臨床環境中重複使用的醫療探頭的安全性和完整性,並受到嚴格的監管指南和行業標準的約束。
根據 MedStar Health 2024 年 1 月發布的資料,美國每年進行超過 700 萬次心臟超音波圖。
醫院感染增加
醫院和診所感染控制的重點是預防因超音波探頭等醫療設備消毒或再處理不當引起的醫療相關感染(HAI)。隨著感染風險的增加,醫療機構正在採用專業、可靠、有效的探針再處理技術來確保病患安全。這增加了對先進清洗和消毒系統的需求,推動了探針再處理市場的發展。
缺乏知識和培訓
缺乏適當的培訓會導致人工清洗錯誤,導致消毒效率低下和醫療探頭供應延誤。這可能會擾亂工作流程並增加患者的治療時間。由於工作流程效率低下,醫療機構可能不願意投資複雜的後處理系統,從而減少了對先進設備和自動化解決方案的需求。這些系統的複雜性以及訓練不足所帶來的挑戰可能會對採用探針再處理最佳實踐產生阻力。
診斷影像的進展
診斷成像探頭變得越來越複雜和精密,需要對其功能和精度進行專門維護。這給探針再處理市場帶來了越來越大的壓力,要求開發能夠保持這些設備完整性的解決方案。市場需要專業、先進的後處理設備來處理複雜的清洗過程,需要更好的消毒劑、自動化清洗系統和高水準的消毒解決方案。因此,將需要專業和先進的後製程設備,以滿足精密、高科技探針的需求。
自動探針再加工設備高成本
自動化探針再處理系統需要大量初步投資,這對於預算有限的小型醫院和醫療中心來說可能是一個挑戰。高成本可能會阻礙設施投資這些技術,特別是當資源分配到其他關鍵領域時。這限制了這些產品的市場,特別是在資源匱乏的環境中,導致感染控制不佳和病患安全風險。製造商可能不願意為服務不足的市場投資負擔得起的系統,這限制了市場成長並抑制創新。
COVID-19 的影響
COVID-19 大流行對探針後處理市場產生了重大影響。隨著人們越來越擔心防止感染傳播,醫院和診所已優先採用自動化、高效的再處理系統,以確保探針的徹底消毒。然而,供應鏈中斷、財務限制以及封鎖期間選擇性程序的減少阻礙了市場成長。儘管有這些挑戰,疫情加速了先進後處理技術的採用,並凸顯了嚴格感染控制的必要性。
預計後處理系統產業在預測期內將是最大的
預計後處理系統領域將在預測期內佔據最大的市場佔有率。透過提高醫療探頭的清洗和消毒效率,醫療機構可以在更短的時間內處理更多的探頭。這改善了患者的通透性並降低了營運成本。程序效率的提高和標準化正在推動對這些技術的需求,隨著醫療保健提供者尋求簡化業務同時遵守嚴格的感染控制標準,從而導致市場顯著成長。
預計手動後處理技術產業在預測期內複合年成長率最高
由於所需的人員和探測時間,醫療機構中的手動再處理是勞力密集且成本高昂的。然而,它們的成本比自動化系統低,這使得它們對預算有限的小型設施具有吸引力。儘管有局限性,但許多設施仍然認為手動再處理是一種實用的解決方案,儘管在大批量處理環境中保持高效率面臨挑戰。
由於北美對包括探頭在內的醫療設備有嚴格的監管標準,需要徹底的後處理通訊協定,因此預計北美地區將在預測期內佔據最大的市場佔有率。 FDA、加拿大衛生署和疾病預防控制中心等機構已實施適當清洗、消毒和滅菌的指南。這些法規增加了對可靠、高效的後處理解決方案的需求,導致手動和自動化系統的採用增加。北美的醫療保健組織面臨著滿足這些嚴格標準的壓力,導致對先進後處理技術(尤其是自動化系統)的需求增加,並推動了市場成長。
亞太地區在日本、韓國和澳洲等已開發國家越來越受歡迎,提供先進的消毒和簡化的流程以減少探針花費的時間,預計在預測期內複合年成長率將達到最高。然而,由於預算限制和基礎設施問題,印度和中國等新興市場仍依賴體力勞動。因此,市場是分散的,根據該地區的醫療開發水平,廣泛使用手動和自動化技術。
According to Stratistics MRC, the Global Probe Reprocessing Market is accounted for $844.8 million in 2024 and is expected to reach $1712.6 million by 2030 growing at a CAGR of 12.5% during the forecast period. Probe reprocessing is the process of cleaning, disinfecting, and sterilizing medical probes and transducers used in diagnostic imaging procedures, such as ultrasound, to prevent cross-contamination and hospital-acquired infections. This process involves multiple steps, including manual cleaning, high-level disinfection, and sterilization, depending on the risk level. Automated systems are often used to improve efficiency and ensure optimal infection control. The goal is to ensure the safety and integrity of medical probes for repeated use in clinical settings, governed by strict regulatory guidelines and industry standards.
According to data released by MedStar Health in January 2024, over 7 million echocardiograms are conducted annually in the U.S.
Increasing incidence of hospital-acquired infections
The focus on infection control in hospitals and clinics is on preventing healthcare-associated infections (HAIs) caused by improper disinfection or reprocessing of medical equipment like ultrasound probes. As the risk of infection increases, healthcare institutions are adopting specialized, reliable, and effective probe reprocessing technologies to ensure patient safety. This has led to increased demand for advanced cleaning and disinfection systems, boosting the probe reprocessing market.
Lack of knowledge and training
Lack of proper training can lead to manual cleaning errors, resulting in inefficient disinfection and delays in medical probe availability. This can disrupt workflow and increase patient care time. Healthcare facilities may be hesitant to invest in complex reprocessing systems due to workflow inefficiencies, reducing demand for advanced equipment and automated solutions. The perceived complexity of these systems and the challenges posed by insufficient training can create resistance in adopting best practices for probe reprocessing.
Advancements in diagnostic imaging
Diagnostic imaging probes are becoming more sophisticated and delicate, necessitating specialized care for their functionality and accuracy. This has increased pressure on the probe reprocessing market to develop solutions that can preserve these devices' integrity. The market demands specialized and advanced reprocessing equipment to handle intricate cleaning processes, requiring better disinfecting agents, automated cleaning systems, and high-level disinfection solutions. As a result, the demand for specialized and advanced reprocessing equipment is expected to meet the needs of delicate and high-tech probes.
High cost of automated probe reprocessors
Automated probe reprocessing systems require significant initial capital investment, which can be a challenge for smaller hospitals and healthcare centers with limited budgets. The high cost can deter facilities from investing in these technologies, especially when resources are allocated to other essential areas. This restricts the market for these products, especially in low-resource settings, leading to poorer infection control and patient safety risks. This limits market growth and stifles innovation, as manufacturers may be reluctant to invest in affordable systems for underserved markets.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the probe reprocessing market, with the heightened focus on preventing the spread of infections, hospitals and clinics prioritized the adoption of automated and high-efficiency reprocessing systems to ensure thorough disinfection of probes. However, supply chain disruptions, financial constraints, and reduced elective procedures during lockdowns hindered market growth. Despite these challenges, the pandemic accelerated the adoption of advanced reprocessing technologies, emphasizing the need for stringent infection control.
The reprocessing systems segment is expected to be the largest during the forecast period
Over the estimation period, the reprocessing systems segment is expected to capture the largest market share enhance the efficiency of cleaning and disinfecting medical probes, allowing healthcare facilities to process more probes in shorter time. This improves patient throughput and reduces operational costs. The increased efficiency and standardized procedures drive demand for these technologies, leading to a significant growth in the market as healthcare providers seek to streamline operations while adhering to strict infection control standards.
The manual reprocessing technology segment is expected to have the highest CAGR during the forecast period
The manual reprocessing technology segment is expected to have the highest CAGR rate during the estimation period owing to manual reprocessing in healthcare facilities can be labor-intensive and expensive due to the need for staff and probe time. However, it remains lower than automated systems, making it attractive to smaller facilities with limited budgets. Despite its limitations, many facilities still find manual reprocessing a practical solution, despite the challenges it presents in maintaining high efficiency in high-volume environments.
Over the forecasted timeframe, the North America region is anticipated to be the largest market share as North America has strict regulatory standards for medical devices, including probes, requiring thorough reprocessing protocols. Agencies like FDA, Health Canada, and CDC have implemented guidelines for proper cleaning, disinfection, and sterilization. These regulations have driven demand for reliable and efficient reprocessing solutions, leading to increased adoption of manual and automated systems. Healthcare institutions in North America are under pressure to meet these rigorous standards, resulting in increased demand for advanced reprocessing technologies, particularly automated systems, fueling market growth.
The Asia Pacific region is anticipated to witness the highest CAGR growth rate throughout the forecast period owing to gaining popularity in developed countries like Japan, South Korea, and Australia, offering a streamlined process for high disinfection and reduced time spent on probes. However, emerging markets like India and China still rely on manual methods due to budget constraints and infrastructure issues. This creates a segmented market, with both manual and automated technologies being widely used depending on the region's healthcare development level.
Key players in the market
Some of the key players in Probe Reprocessing market include ASP (Fortive Corporation), CIVCO Medical Solutions, CS Medical LLC, Ecolab, GE Healthcare, Germitec, Metrex Research, LLC, Nanosonics, Parker Laboratories Inc, Schulke & Mayr GmbH, Steelco S.p.A., STERIS, Tristel Plc and Virox Technologies Inc.
In December 2024, GE HealthCare unveiled three new advanced deep learning image processing and reconstruction solutions as a part of its Effortless Recon DL portfolio at the Radiological Society of North America (RSNA) 2024 Annual Meeting, in Chicago, IL.
In December 2024, GE HealthCare has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd, by purchasing from Sumitomo Chemical the 50% stake it does not already own. As part of GE HealthCare, NMP can build on its expertise developing and manufacturing proprietary and in-licensed radiopharmaceuticals.
In November 2024, Ecolab announced the acquisition of Barclay Water Management, a fast-growing provider of water safety and digital monitoring solutions for industrial and institutional customers based primarily in the northeastern United States.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.